GAP-f
@GAP_f_Network
Followers
233
Following
45
Media
80
Statuses
177
The GAP-f Network is hosted by WHO and was created to address the gap in paediatric medicines through coordination and collaboration among key stakeholders
Geneva, Switzerland
Joined April 2021
🌍 World Children’s Day reminds us why we do this work. Grateful to all our partners who move with us toward one goal: better #medicines for every #child. 🎥 Sharing a short video that captures our “why.” https://t.co/AFeGuMvQYQ
#WorldChildrensDay #BetterMeds4Kids #GAPf #WHO
9
3
6
In the run-up to #WorldChildrensDay, the first-ever PADO for #Malaria report is now live! This @WHO -led process sets priority actions to accelerate development & access to optimal malaria treatments for children. It also aligns with ongoing WHO work — including the review of
0
0
4
📢Reminder: Call for consultation: Draft Target Product Profile for a paediatric formulation of Hydroxyurea! @WHO is seeking feedback on hydroxyurea draft TPPs. The draft TPP and the feedback forms can be found here 👉 https://t.co/6aMcCmiUcv 📅 Deadline for the call is 7
who.int
Hydroxyurea (HU) also known as hydroxycarbamide, is an oral antineoplastic drug and an inhibitor of ribonucleotide reductase that has shown to have many beneficial effects for treating sickle cell...
0
0
0
📢Calling industry partners to be part of the global effort to accelerate better medicines for children. 🌏GAP-f works through an ecosystem approach to close gaps in paediatric medicines. The private sector is a key partner in accelerating innovation and access for #children.
forms.office.com
0
0
0
📢Delighted to amplify the new #WHO Model List of Essential Medicines for Children 📘 GAP-f contributed by assessing age appropriateness of approximately 290 #medicines using the #QTPP tool to inform removal of 92 outdated formulations & addition of 163 new ones- a big step for
who.int
Essential medicines are those that satisfy the priority health care needs of a population. They are selected with due regard to disease prevalence and public health relevance, evidence of efficacy...
0
0
0
Many essential medicines are not designed for children. That means crushed pills, inaccurate doses, and bitter tastes that make treatment hard to take. @GAP_f_Network is working to close this gap. 🔗 https://t.co/GoJVFjUdJI
#HealthForAll
17
71
165
Too many children are given medicines that were never properly tested for them. That means imprecise dosing—and real risks. 💡 The @GAP_f_Network is changing the game. They’re fast-tracking the development of medicines made for children—not just scaled-down versions of adult
23
48
132
The @GAP_f_Network is improving access to medicines designed for children — but it can’t do it alone. It takes a village. Ensuring children get access to the medicines they need means working hand-in-hand with communities, countries, regulators, funders, private sector
13
22
89
The new strategy to invest in children’s health by @GAP_f_Network sets a clear direction for 2030: 🔹 Focus on the most urgent diseases 🔹 Speed up access to key medicines 🔹 Strengthen the paediatric medicines ecosystem A $40M investment means lives saved with no time lost.
16
33
120
📢First-Ever PADO for #RSV Report Released! Led by @WHO, it sets key R&D + access priorities to prevent & treat #RSV in kids over the next 3–10 yrs. Find out more👇 https://t.co/hR3zffDsUn
#Bettermeds4kids
0
1
1
Looking forward to welcoming you all to the launch today. There is still time to register here
📢 Join us for the next #BetterMeds4Kids webinar! 🗓️ 8 July 2025 | 🕑 14:00–15:00 CEST 🌍 Topic: Optimizing tools for the prevention and treatment of RSV disease in children: Priorities and the Path Forward 📄 Featuring the launch of GAP-f’s PADO report on RSV 🔗 Register now:
0
0
2
📢 Join us for the next #BetterMeds4Kids webinar! 🗓️ 8 July 2025 | 🕑 14:00–15:00 CEST 🌍 Topic: Optimizing tools for the prevention and treatment of RSV disease in children: Priorities and the Path Forward 📄 Featuring the launch of GAP-f’s PADO report on RSV 🔗 Register now:
0
0
0
📣GAP-f has just launched its 2025–2030 Strategy with a bold goal: ✅ 10 diseases ✅ 10 medicines ✅ 10 countries All by 2030. Because every child deserves timely access to the medicines they need. 📄 Learn more 👉WHO launches global accelerator for Paediatric Formulations
1
6
11
🔍 New study reveals critical gaps in paediatric medicines on national essential medicines lists—especially in LMICs. Our children’s health is at risk. This is why our collective work is more important than ever. 🚨 It's time for equitable access to #BetterMeds4Kids. 📖 Read
frontiersin.org
BackgroundChildren need specialized medicine formulations for proper dosing, safety, and adherence. The World Health Organization developed a pediatric essen...
0
4
3
📢Join us at the 78th World Health Assembly for a high-level side event on advancing access to paediatric medicines! 📅 20 May 2025, 🕰️18:30–20:30 CET at Jardin de Penthes, Geneva 🚀Let's strengthen the global ecosystem for #children's #health together! 🔗 https://t.co/7bYeftTm02
0
6
9
📢Just published in The Lancet Child & Adolescent Health! "Simplifying medicine dosing for children by harmonising weight bands across therapeutic areas" 💊 A step toward simplifying and standardising paediatric treatment globally. 📄 Read: https://t.co/B0um7rrS6N
#ChildHealth
pubmed.ncbi.nlm.nih.gov
Generally, dose recommendations for children are expressed as fixed dosing increments related to bodyweight, known as weight bands. The weight bands recommended in WHO treatment guidelines vary...
0
2
0
📢 The Target Product Profiles for priority #paediatric formulations of azithromycin & nitrofurantoin are now available! 📄👇 🔗 https://t.co/lJLCIQ70iX Interested #Manufacturers are invited to submit an EOI for product evaluation to #WHO 🔗 Please see
0
0
0
We look forward to seeing you all at the webinar today! There is still time to register 👉 https://t.co/iRCreOwpRZ 📄 Agenda 👇
📢 Save the date! Join us for our upcoming webinar on Investigating and developing better antibiotics for children: What Can We Do Now and Next? 📅 March 4, 2025 ⏰1400-1500 CET Register here 👉 https://t.co/iRCreOvS2r
0
0
1
📢 Save the date! Join us for our upcoming webinar on Investigating and developing better antibiotics for children: What Can We Do Now and Next? 📅 March 4, 2025 ⏰1400-1500 CET Register here 👉 https://t.co/iRCreOvS2r
0
10
13
🎉 We are excited to share our recently published meeting report from the first Paediatric Drug Optimization (PADO) meeting for childhood cancer medicines. 📑This report outlines the discussions & outcomes of the @GAP_f_Network @WHO-led PADO process, a strategic approach to
0
3
7